Post Operative Adjuvant Chemotherapy Followed by Adjuvant Tamoxifen vs Nil for Patients With Operable Breast Cancer

King Faisal Specialist Hospital & Research Center

Status: Unknown

Conditions: Breast Cancer

Treatments: Drug: Tamoxifen

Study type: Interventional

Funder types: Other

Identifiers

NCT00538330

RAC #93-107

Details and patient eligibility

About

Post operative adjuvant chemotherapy followed by adjuvant Tamoxifen vs nil for patients with operable breast cancer

Enrollment: 2,000 estimated patients

Sex: All

Volunteers: No Healthy Volunteers

Inclusion and exclusion criteria

Inclusion Criteria:

• Patients with operable breast cancer

Trial design

Primary purpose: Health Services Research

Allocation: N/A

Interventional model: Single Group Assignment

Masking: None (Open label)